A Multi-center, Dose-escalation Study of Human type I Pancreatic Elastase (PRT-201) Administered after Arteriovenous Fistula Creation - Concepedia

Concepedia

Publication | Open Access

A Multi-center, Dose-escalation Study of Human type I Pancreatic Elastase (PRT-201) Administered after Arteriovenous Fistula Creation

DOI Full Paper Access

55

Citations

20

References

2012

Year

Eric K. Peden, David B. Leeser, Bradley S. Dixon, Mahmoud El‐Khatib, Prabir Roy‐Chaudhury, Jeffrey H. Lawson, Matthew T. Menard, Laura M. Dember, Marc H. Glickman, Pamela N. Gustafson,

The Journal of Vascular Access

Abstract

PRT-201 was not different from placebo for safety or efficacy measures. There was a suggestion for improved AVF primary patency with Low Dose PRT-201 that is now being studied in a larger clinical trial.

References

	Year	Citations

Page 1